EFX vs KYMR · P/E 54, rev $3.35B vs rev $99.4M
Equifax Inc (EFX) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the EFX and KYMR stock pages for the full models.
Not investment advice.